Design
Review
Authors
Loading...
Antibody-centric FMD vaccines may be refined by antigenic and Th-epitope targeting; leaves open optimal combinations for durable protection.
Key points are not available for this paper at this time.
McCullough et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: